Sufu limits sepsis-induced lung inflammation via regulating phase separation of TRAF6
Yehua Li, Jiayin Peng, Yuanxin Xia(University of Chinese Academy of Sciences), Chenyu Pan, Yu Li, Weijie Gu(University of Chinese Academy of Sciences), Jia Wang(University of Chinese Academy of Sciences), Chaoxiong Wang(University of Chinese Academy of Sciences), Yuang Wang(University of Chinese Academy of Sciences), Jiawen Song(University of Chinese Academy of Sciences), Xuan Zhou(University of Chinese Academy of Sciences), Liya Ma(University of Chinese Academy of Sciences), Yiao Jiang(University of Chinese Academy of Sciences), Biao Liu(University of Chinese Academy of Sciences), Qiongni Feng(University of Chinese Academy of Sciences), Wenjia Wang(Zhongshan Hospital), Shi Jiao(University of Chinese Academy of Sciences), Liwei An, Dianfan Li(University of Chinese Academy of Sciences), Zhaocai Zhou(University of Chinese Academy of Sciences), Yun Zhao(University of Chinese Academy of Sciences)
Cited by 31Open Access
Abstract
These findings implicated Sufu as an important inhibitor of TRAF6 in sepsis and suggest that therapeutics targeting Sufu-TRAF6 may greatly benefit the treatment of sepsis.
Related Papers
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Agnieszka Płóciennikowska, Aneta Hromada‐Judycka, Kinga Borzęcka et al.|Cellular and Molecular Life Sciences|2014|756